Study of the Role of Anti-Cancer Molecules with Different Sizes for Decreasing Corresponding Bulk Tumor Multiple Organs or Tissues
A Heidari
The intermolecular forces between anti–cancer molecules such as Cisplatin, Carboplatin, Oxaliplatin, Nedaplatin, Lobaplation, Heptaplatin, Dicycloplatin, Eleutherobin, Epothilone B, Discodermolide and Taxol and tumor multiple organs or tissues are of great importance in many areas of science including medicine, chemotherapy, pharmacology, medicinal chemistry, pharmaceutical chemistry, biochemistry and so on. As a result, these molecular systems have received a great significant of attention in both computational and theoretical aspects.
